Attributable one‐year healthcare cost of incident type 2 diabetes: A population‐wide difference‐in‐differences study in Denmark
Authors' conclusion
The majority of the first year health care cost of incident diabetes is incurred at the hospital level followed by primary care and medication. Our yearly cost estimate per newly diagnosed is considerably lower than estimates from the US and Australia.
Study context
- Population
- Entire Danish population 2016–2019; individuals newly diagnosed with T2D in 2018, followed 2 years before and 1 year after diagnosismatched 1:1
- Participants
- 18,133 participants
- Exposure
- Newly diagnosed T2D vs matched controls
- Outcome
- Attributable healthcare costs (medication, primary and secondary healthcare)
- Follow-up
- One year after diagnosis
Methodological detailsdifference-in-differences design, matched 1:1 control group, Danish registry data
- Difference-in-differences design
- Matched 1:1 control group
- Danish registry data
Main finding
As reported in the abstract
Attributable healthcare cost of T2D per individual · one year
Total attributable one-year cost
EUR 1316
Hospital care
EUR 1004
Primary care
EUR 167
Observational data: associations, not effects.
Further findings
Total attributable cost of incident diabetes in Denmark in 2018
- Total national attributable cost
- approx. EUR 24 million
Original publication
Attributable one‐year healthcare cost of incident type 2 diabetes: A population‐wide difference‐in‐differences study in Denmark. Diabet Med. Published 16 October 2024. doi:10. 1111/ dme. 15455
Composed by AI from the published abstract and checked against it. How Briefs are made →